Risk factors for severe postpartum hemorrhage: a case-control study

Lill Trine Nyfløt, Irene Sandven, Babill Stray-Pedersen, Silje Pettersen, Iqbal Al-Zirqi, Margit Rosenberg, Anne Flem Jacobsen, Siri Vangen, Lill Trine Nyfløt, Irene Sandven, Babill Stray-Pedersen, Silje Pettersen, Iqbal Al-Zirqi, Margit Rosenberg, Anne Flem Jacobsen, Siri Vangen

Abstract

Background: In high-income countries, the incidence of severe postpartum hemorrhage (PPH) has increased. This has important public health relevance because severe PPH is a leading cause of major maternal morbidity. However, few studies have identified risk factors for severe PPH within a contemporary obstetric cohort.

Methods: We performed a case-control study to identify risk factors for severe PPH among a cohort of women who delivered at one of three hospitals in Norway between 2008 and 2011. A case (severe PPH) was classified by an estimated blood loss ≥1500 mL or the need for blood transfusion for excessive postpartum bleeding. Using logistic regression, we applied a pragmatic strategy to identify independent risk factors for severe PPH.

Results: Among a total of 43,105 deliveries occurring between 2008 and 2011, we identified 1064 cases and 2059 random controls. The frequency of severe PPH was 2.5% (95% confidence interval (CI): 2.32-2.62). The most common etiologies for severe PPH were uterine atony (60%) and placental complications (36%). The strongest risk factors were a history of severe PPH (adjusted OR (aOR) = 8.97, 95% CI: 5.25-15.33), anticoagulant medication (aOR = 4.79, 95% CI: 2.72-8.41), anemia at booking (aOR = 4.27, 95% CI: 2.79-6.54), severe pre-eclampsia or HELLP syndrome (aOR = 3.03, 95% CI: 1.74-5.27), uterine fibromas (aOR = 2.71, 95% CI: 1.69-4.35), multiple pregnancy (aOR = 2.11, 95% CI: 1.39-3.22) and assisted reproductive technologies (aOR = 1.88, 95% CI: 1.33-2.65).

Conclusions: Based on our findings, women with a history of severe PPH are at highest risk of severe PPH. As well as other established clinical risk factors for PPH, a history of severe PPH should be included as a risk factor in the development and validation of prediction models for PPH.

Keywords: Case-control study; High-risk; Obstetric interventions; Postpartum hemorrhage; Prediction; Predictors; Prevention; Risk factors.

References

    1. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ. 2001;322:1089–93. doi: 10.1136/bmj.322.7294.1089.
    1. Zhang WH, Alexander S, Bouvier-Colle MH, Macfarlane A, Group M-B. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG. 2005;112:89–96. doi: 10.1111/j.1471-0528.2004.00303.x.
    1. Mantel GD, Buchmann E, Rees H, Pattinson RC. Severe acute maternal morbidity: a pilot study of a definition for a near-miss. BJOG. 1998;105:985–90. doi: 10.1111/j.1471-0528.1998.tb10262.x.
    1. Brace V, Penney G, Hall M. Quantifying severe maternal morbidity: a Scottish population study. BJOG. 2004;111:481–4. doi: 10.1111/j.1471-0528.2004.00101.x.
    1. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the international postpartum hemorrhage collaborative group. BMC Pregnancy Childbirth. 2009;9:55. doi: 10.1186/1471-2393-9-55.
    1. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110:1368–73. doi: 10.1213/ANE.0b013e3181d74898.
    1. Kramer MS, Dahhou M, Vallerand D, Liston R, Joseph KS. Risk factors for postpartum hemorrhage: can we explain the recent temporal increase? J Obstet Gynaec Can. 2011;33:810–9. doi: 10.1016/S1701-2163(16)34984-2.
    1. Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obst Gynecol. 2013;209:449.e1–7. doi: 10.1016/j.ajog.2013.07.007.
    1. Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet. 2007;98:237–43. doi: 10.1016/j.ijgo.2007.03.011.
    1. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010;202:353. doi: 10.1016/j.ajog.2010.01.011.
    1. Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF, et al. Investigation of an increase in postpartum haemorrhage in Canada. BJOG. 2007;114:751–9. doi: 10.1111/j.1471-0528.2007.01316.x.
    1. Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol. 2011;118:561–8. doi: 10.1097/AOG.0b013e31822a6c59.
    1. American College of Obstetricians and Gynecologists ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108:1039–47. doi: 10.1097/00006250-200610000-00046.
    1. Akins S. Postpartum hemorrhage. A 90s approach to an age-old problem. J Nurse Midwifery. 1994;39(Suppl 2):123S–34S. doi: 10.1016/0091-2182(94)90070-1.
    1. American College of Obstetricians and Gynecologists Practice bulletin No. 173: fetal macrosomia. Obstet Gynecol. 2016;128:e195–e209. doi: 10.1097/AOG.0000000000001767.
    1. World Health Organization. Definition of WHO regions. Available from: . Accessed 10 Apr 2016.
    1. Norwegian Institute of Public Health. The Medical Birth Registry of Norway. Available from: . Accessed 10 Apr 2016.
    1. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115:1265–72. doi: 10.1111/j.1471-0528.2008.01859.x.
    1. Abdelnoor M, Sandven I. Explanatory versus prognostic strategy in clinical research. Nor Epidemiol. 2006;16:77–80.
    1. Kleinbaum DG, Kupper LL, Morgenstern H. Principles and quantitative methods. Epidemiologic research. New York: Wiley; 1982.
    1. Kleinbaum DG, Klein M. Logistic regression. A self-learning text. 3 ed. New York: Springer; 2010.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296. doi: 10.1371/journal.pmed.0040296.
    1. Glover P. Blood loss at delivery: how accurate is your estimation? Austr J Midwifery. 2003;16:21–4. doi: 10.1016/S1031-170X(03)80005-3.
    1. Coker A, Oliver R. Definitions and classifications. In: B-Lynch C, Keith L, Lalonde A, Karoshi M, editors. A textbook of postpartum hemorrhage. 1 ed. Duncow: Sapiens Publishing; 2006.
    1. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Medical J. 2005;98:419–22. doi: 10.1097/01.SMJ.0000152760.34443.86.
    1. Ford JB, Roberts CL, Bell JC, Algert CS, Morris JM. Postpartum haemorrhage occurrence and recurrence: a population-based study. Med J Austr. 2007;187:391–3.
    1. Oberg AS, Hernandez-Diaz S, Palmsten K, Almqvist C, Bateman BT. Patterns of recurrence of postpartum hemorrhage in a large population-based cohort. Am J Obst Gynecol. 2014;210:229. doi: 10.1016/j.ajog.2013.10.872.
    1. Ford JB, Algert CS, Kok C, Choy MA, Roberts CL. Hospital data reporting on postpartum hemorrhage: under-estimates recurrence and over-estimates the contribution of uterine atony. Matern Child Health J. 2012;16:1542–8. doi: 10.1007/s10995-011-0919-1.
    1. Oberg AS, Hernandez-Diaz S, Frisell T, Greene MF, Almqvist C, Bateman BT. Genetic contribution to postpartum haemorrhage in Swedish population: cohort study of 466,686 births. BMJ Open. 2014;349:g4984. doi: 10.1136/bmj.g4984.
    1. Lindqvist PG, Bremme K, Hellgren M, Hem-ARG Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism. Acta Obstet Gynecol Scand. 2011;90:648–53. doi: 10.1111/j.1600-0412.2011.01098.x.
    1. Roshani S, Cohn DM, Stehouwer AC, Wolf H, van der Post JA, Buller HR, et al. Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study. BMJ Open. 2011;1:e000257. doi: 10.1136/bmjopen-2011-000257.
    1. Knol HM, Schultinge L, Veeger NJ, Kluin-Nelemans HC, Erwich JJ, Meijer K. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy. Thromb Res. 2012;130:334–8. doi: 10.1016/j.thromres.2012.03.007.
    1. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Effects of onset of labor and mode of delivery on severe postpartum hemorrhage. Am J Obst Gynecol. 2009;201:273. doi: 10.1016/j.ajog.2009.06.007.
    1. Belghiti J, Kayem G, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C. Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case–control study. BMJ Open. 2011;1:e000514. doi: 10.1136/bmjopen-2011-000514.
    1. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med. 2005;18:149–54. doi: 10.1080/14767050500170088.
    1. Khireddine I, Le Ray C, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C. Induction of labor and risk of postpartum hemorrhage in low risk parturients. PLoS One. 2013;8:e54858. doi: 10.1371/journal.pone.0054858.
    1. Phaneuf S, Asboth G, Carrasco MP, Europe-Finner GN, Saji F, Kimura T, et al. The desensitization of oxytocin receptors in human myometrial cells is accompanied by down-regulation of oxytocin receptor messenger RNA. J Endocrinol. 1997;154:7–18. doi: 10.1677/joe.0.1540007.
    1. Phaneuf S, Rodriguez Linares B, TambyRaja RL, MacKenzie IZ, Lopez BA. Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour. J Reprod Fertil. 2000;120:91–7. doi: 10.1530/reprod/120.1.91.
    1. Magalhaes JK, Carvalho JC, Parkes RK, Kingdom J, Li Y, Balki M. Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner. Reprod Sci. 2009;16:501–8. doi: 10.1177/1933719108329954.
    1. Healy DL, Breheny S, Halliday J, Jaques A, Rushford D, Garrett C, et al. Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod. 2010;25:265–74. doi: 10.1093/humrep/dep376.
    1. Kallen B, Finnstrom O, Nygren KG, Otterblad Olausson P, Wennerholm UB. In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality. BJOG. 2005;112:1529–35. doi: 10.1111/j.1471-0528.2005.00745.x.
    1. Hayashi M, Nakai A, Satoh S, Matsuda Y. Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used. Fertil Steril. 2012;98:922–8. doi: 10.1016/j.fertnstert.2012.05.049.
    1. Lain SJ, Roberts CL, Hadfield RM, Bell JC, Morris JM. How accurate is the reporting of obstetric haemorrhage in hospital discharge data? A validation study. Aust NZ J Obstet Gynaecol. 2008;48(5):481–4. doi: 10.1111/j.1479-828X.2008.00910.x.
    1. Mhyre JM, Shilkrut A, Kuklina EV, Callaghan WM, Creanga AA, Kaminsky S, et al. Massive blood transfusion during hospitalization for delivery in New York state, 1998–2007. Obstet Gynecol. 2013;122:1288–94. doi: 10.1097/AOG.0000000000000021.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera